PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer

Scerri, Jeanesse; Scerri, Christian; Schaefer-Ruoff, Felix; Fink, Simon; Templin, Markus; Grech, Godfrey

dc.contributor.author	Fink, Simon
dc.contributor.author	Schäfer-Ruoff, Felix
dc.contributor.author	Templin, Markus F.
dc.date.accessioned	2023-05-23T06:29:41Z
dc.date.available	2023-05-23T06:29:41Z
dc.date.issued	2022
dc.identifier.issn	1664-2392
dc.identifier.uri	http://hdl.handle.net/10900/141326
dc.language.iso	en	de_DE
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fendo.2022.1010092	de_DE
dc.subject.ddc	610	de_DE
dc.title	PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_00848
utue.personen.roh	Scerri, Jeanesse
utue.personen.roh	Scerri, Christian
utue.personen.roh	Schaefer-Ruoff, Felix
utue.personen.roh	Fink, Simon
utue.personen.roh	Templin, Markus
utue.personen.roh	Grech, Godfrey
dcterms.isPartOf.ZSTitelID	Frontiers in Endocrinology	de_DE
dcterms.isPartOf.ZS-Issue	Article 1010092	de_DE
dcterms.isPartOf.ZS-Volume	13	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE